Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikulaa Parachuri

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Eye (London, England)|December 18, 2019
Immunogenicity and efficacy after switching from original Ranibizumab to a Ranibizumab biosimilar: real-world dataAshish Sharma, M Hafeez Faridi, Nilesh Kumar, et al.
Eye (London, England)|August 9, 2020
Correction: MII RetCam assisted smartphone-based fundus imaging (MSFI)-a boon for paediatric retinal imagingRajwinder Kaur, Harijot Singh, Shallu Samria, et al.
Eye (London, England)|February 29, 2020
MII RetCam assisted smartphone-based fundus imaging (MSFI)-A boon for paediatric retinal imagingRajwinder Kaur, Harijot Singh, Shallu Samria, et al.
Retina (Philadelphia, Pa.)|December 15, 2021
MYTHS AND TRUTHS OF THE ASSOCIATION OF RETINAL VASCULAR OCCLUSION WITH COVID-19Ashish Sharma, Nikulaa Parachuri, Nilesh Kumar, et al.
Eye (London, England)|July 26, 2020
Brolucizumab-early real-world experience: BREW studyAshish Sharma, Nilesh Kumar, Nikulaa Parachuri, et al.
Eye (London, England)|December 16, 2020
Correction: Brolucizumab-early real-world experience: BREW studyAshish Sharma, Nilesh Kumar, Nikulaa Parachuri, et al.
Retina (Philadelphia, Pa.)|December 3, 2021
ReplyAshish Sharma, Chui Ming Gemmy Cheung, Luis Arias-Barquet, et al.
Retina (Philadelphia, Pa.)|July 13, 2021
FLUID-BASED VISUAL PROGNOSTICATION IN TYPE 3 MACULAR NEOVASCULARIZATION-FLIP-3 STUDYAshish Sharma, Chui Ming Gemmy Cheung, Luis Arias-Barquet, et al.
Eye (London, England)|August 3, 2024
Subfoveal neurosensory detachment flattening and observe (SNF-Ob) approach for the management of Ci-DMO - a multicentric studyAshish Sharma, Taku Wakabayashi, Carl D Regillo, et al.
Journal of Vitreoretinal Diseases|March 3, 2025
Biosimilar Ranibizumab (Ranieyes) Safety and Efficacy in the Real World: BRESER StudyAshish Sharma, Frank G Holz, Nilesh Kumar, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Eye (London, England)|December 18, 2019
Immunogenicity and efficacy after switching from original Ranibizumab to a Ranibizumab biosimilar: real-world dataAshish Sharma, M Hafeez Faridi, Nilesh Kumar, et al.
Eye (London, England)|August 9, 2020
Correction: MII RetCam assisted smartphone-based fundus imaging (MSFI)-a boon for paediatric retinal imagingRajwinder Kaur, Harijot Singh, Shallu Samria, et al.
Eye (London, England)|February 29, 2020
MII RetCam assisted smartphone-based fundus imaging (MSFI)-A boon for paediatric retinal imagingRajwinder Kaur, Harijot Singh, Shallu Samria, et al.
Retina (Philadelphia, Pa.)|December 15, 2021
MYTHS AND TRUTHS OF THE ASSOCIATION OF RETINAL VASCULAR OCCLUSION WITH COVID-19Ashish Sharma, Nikulaa Parachuri, Nilesh Kumar, et al.
Eye (London, England)|July 26, 2020
Brolucizumab-early real-world experience: BREW studyAshish Sharma, Nilesh Kumar, Nikulaa Parachuri, et al.
Eye (London, England)|December 16, 2020
Correction: Brolucizumab-early real-world experience: BREW studyAshish Sharma, Nilesh Kumar, Nikulaa Parachuri, et al.
Retina (Philadelphia, Pa.)|December 3, 2021
ReplyAshish Sharma, Chui Ming Gemmy Cheung, Luis Arias-Barquet, et al.
Retina (Philadelphia, Pa.)|July 13, 2021
FLUID-BASED VISUAL PROGNOSTICATION IN TYPE 3 MACULAR NEOVASCULARIZATION-FLIP-3 STUDYAshish Sharma, Chui Ming Gemmy Cheung, Luis Arias-Barquet, et al.
Eye (London, England)|August 3, 2024
Subfoveal neurosensory detachment flattening and observe (SNF-Ob) approach for the management of Ci-DMO - a multicentric studyAshish Sharma, Taku Wakabayashi, Carl D Regillo, et al.
Journal of Vitreoretinal Diseases|March 3, 2025
Biosimilar Ranibizumab (Ranieyes) Safety and Efficacy in the Real World: BRESER StudyAshish Sharma, Frank G Holz, Nilesh Kumar, et al.
Pageof 7